EDWARDS LIFESCIENCES A/S: Financial statements 2012
CVR: 25045270
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
EDWARDS LIFESCIENCES A/S (CVR 25045270) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 7,238,000 and a net result of DKK 409,298,000. Equity in the 2012 report amounted to DKK 3,946,000. The solvency ratio was 51.2%.
- Gross Profit
- DKK 7,238,000
- Profit/Loss
- DKK 409,298,000
- Equity
- DKK 3,946,000
- Total Assets
- DKK 7,700,000
Official annual report
Keep an eye on EDWARDS LIFESCIENCES A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of September 18, 2012, Jean-Francois Beyrath has joined the board of directors of EDWARDS LIFESCIENCES A/S.
As of September 18, 2012, David Ronald Jones has left the board of directors of EDWARDS LIFESCIENCES A/S.
As of September 18, 2012, Jean-Francois Beyrath is registered as director of EDWARDS LIFESCIENCES A/S.
As of September 18, 2012, David Ronald Jones has stepped down as adm. dir. of EDWARDS LIFESCIENCES A/S.
As of February 1, 2012, David Ronald Jones has joined the board of directors of EDWARDS LIFESCIENCES A/S.
As of February 1, 2012, Patrick Bruno Noel Verguet has left the board of directors of EDWARDS LIFESCIENCES A/S.
As of February 1, 2012, David Ronald Jones is registered as adm. dir. of EDWARDS LIFESCIENCES A/S.
As of February 1, 2012, Patrick Bruno Noel Verguet has stepped down as adm. dir. of EDWARDS LIFESCIENCES A/S.
About EDWARDS LIFESCIENCES A/S
EDWARDS LIFESCIENCES A/S is a Danish company of the type Aktieselskab based in København S, founded in 1999. The company is registered under the industry Agenturhandel med specialiseret varesortiment, bortset fra køretøjer. The company was previously named EDWARDS LIFESCIENCES HOLDING A/S and A/S PSE 38 NR. 2095. The management consists of Patrice Lucien Pascal Cappelle. The board consists of Andrew Michael Dahl, Linda Park and Patrice Lucien Pascal Cappelle. The company is owned by Edwards Lifesciences (U.S.) Inc.. The company has 8 employees (2026). In 2025, the company reported a gross profit of DKK 15,830,000 and a net result of DKK 3,006,000 compared with DKK 8,257,429 the year before. Equity in the 2025 report amounted to DKK 32,577,000.
